4.7 Article

Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141

Journal

NATURE IMMUNOLOGY
Volume 6, Issue 2, Pages 181-188

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni1156

Keywords

-

Categories

Funding

  1. MRC [G9827961, G0300180] Funding Source: UKRI
  2. Medical Research Council [G9827961, G0300180] Funding Source: researchfish
  3. Medical Research Council [G0500617(74644), G9827961, G0500617, G0300180, G0300180(65735)] Funding Source: Medline
  4. Wellcome Trust [066749] Funding Source: Medline

Ask authors/readers for more resources

Natural killer (NK) cells are crucial in the control of cytomegalovirus infections in mice and humans. Here we show that the viral UL141 gene product has an immunomodulatory function that is associated with low-passage strains of human cytomegalovirus. UL141 mediated efficient protection of cells against killing by a wide range of human NK cell populations, including interferon-alpha- stimulated bulk cultures, polyclonal NK cell lines and most NK cell clones tested. Evasion of NK cell killing was mediated by UL141 blocking surface expression of CD155, which was previously identified as a ligand for NK cell-activating receptors CD226 (DNAM-1) and CD96 (TACTILE). The breadth of the UL141-mediated effect indicates that CD155 has a key role in regulating NK cell function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available